CATX

Perspective Therapeutics Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 3/10
  • Value↓ 0/10
Perspective Therapeutics sales and earnings growth
CATX Growth
Neutral
  • Revenue Y/Y↓ -72.69%
  • EPS Y/Y↓ -12.00%
  • FCF Y/Y↓ -3.81%
Perspective Therapeutics gross and profit margin trends
CATX Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -17982.70%
  • ROIC 5Y↓ -166.58%
Perspective Therapeutics net debt vs free cash flow
CATX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -316.1

Perspective Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Medical Devices stocks